Avai Bio (AVAI) Notes Payables (2018 - 2023)
Avai Bio's Notes Payables history spans 4 years, with the latest figure at $295500.0 for Q4 2023.
- For Q4 2023, Notes Payables rose 74.34% year-over-year to $295500.0; the TTM value through Dec 2023 reached $295500.0, up 74.34%, while the annual FY2023 figure was $294600.0, N/A changed from the prior year.
- Notes Payables for Q4 2023 was $295500.0 at Avai Bio, up from $169500.0 in the prior quarter.
- Across five years, Notes Payables topped out at $295500.0 in Q4 2023 and bottomed at $2746.0 in Q1 2020.
- The 3-year median for Notes Payables is $169500.0 (2022), against an average of $147618.9.
- The largest YoY upside for Notes Payables was 304.46% in 2023 against a maximum downside of 0.0% in 2023.
- A 3-year view of Notes Payables shows it stood at $59601.0 in 2020, then surged by 184.39% to $169500.0 in 2022, then surged by 74.34% to $295500.0 in 2023.
- Per Business Quant, the three most recent readings for AVAI's Notes Payables are $295500.0 (Q4 2023), $169500.0 (Q3 2023), and $294600.0 (Q2 2023).